130 related articles for article (PubMed ID: 3487639)
1. Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor.
Förstermann U; Goppelt-Strübe M; Frölich JC; Busse R
J Pharmacol Exp Ther; 1986 Jul; 238(1):352-9. PubMed ID: 3487639
[TBL] [Abstract][Full Text] [Related]
2. Thimerosal, an inhibitor of endothelial acyl-coenzyme A: lysolecithin acyltransferase, stimulates the production of a nonprostanoid endothelium-derived vascular relaxing factor.
Förstermann U; Goppelt-Strübe M; Frölich JC; Busse R
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1108-11. PubMed ID: 2960154
[TBL] [Abstract][Full Text] [Related]
3. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
Bassenge E; Busse R; Pohl U
Circ Res; 1987 Nov; 61(5 Pt 2):II68-73. PubMed ID: 3117407
[TBL] [Abstract][Full Text] [Related]
4. Thimerosal induces endothelium-dependent vascular smooth muscle relaxations by interacting with thiol groups. Relaxations are likely to be mediated by endothelium-derived relaxing factor (EDRF).
Förstermann U; Burgwitz K; Frölich JC
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):501-7. PubMed ID: 3102978
[TBL] [Abstract][Full Text] [Related]
5. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors.
Rubanyi GM; McKinney M; Vanhoutte PM
J Pharmacol Exp Ther; 1987 Mar; 240(3):802-8. PubMed ID: 2435886
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
Blaise GA; Stewart DJ; Guérard MJ
Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
[TBL] [Abstract][Full Text] [Related]
7. Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery.
Guo HY; Loren RR; Vanhutte PM
Chin Med J (Engl); 1992 Aug; 105(8):666-70. PubMed ID: 1458970
[TBL] [Abstract][Full Text] [Related]
8. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic characteristics of non-prostanoid, non-nitric oxide mediated and endothelium-dependent relaxation of guinea-pig aorta in response to substance P.
Tanaka Y; Kaneko H; Tanaka H; Shigenobu K
Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):65-81. PubMed ID: 10440572
[TBL] [Abstract][Full Text] [Related]
10. NO/PGI2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery.
Dong H; Waldron GJ; Galipeau D; Cole WC; Triggle CR
Br J Pharmacol; 1997 Feb; 120(4):695-701. PubMed ID: 9051310
[TBL] [Abstract][Full Text] [Related]
11. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
Rubanyi GM; Desiderio D; Luisi A; Johns A; Sybertz EJ
J Pharmacol Exp Ther; 1989 Jun; 249(3):858-63. PubMed ID: 2499677
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
Jia L; Furchgott RF
J Pharmacol Exp Ther; 1993 Oct; 267(1):371-8. PubMed ID: 8229764
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
Shikano K; Berkowitz BA
J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
[TBL] [Abstract][Full Text] [Related]
15. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase.
Mülsch A; Busse R; Liebau S; Förstermann U
J Pharmacol Exp Ther; 1988 Oct; 247(1):283-8. PubMed ID: 2902213
[TBL] [Abstract][Full Text] [Related]
16. Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.
Prieto D; Simonsen U; Hernández M; García-Sacristán A
Br J Pharmacol; 1998 Apr; 123(8):1609-20. PubMed ID: 9605568
[TBL] [Abstract][Full Text] [Related]
17. EDHF mediates the relaxation of stretched canine femoral arteries to acetylcholine.
Woodley N; Meunier RL; Barclay JK
Can J Physiol Pharmacol; 2001 Nov; 79(11):924-31. PubMed ID: 11760094
[TBL] [Abstract][Full Text] [Related]
18. Ouabain inhibits endothelium-dependent relaxations to arachidonic acid in canine coronary arteries.
Rubanyi GM; Vanhoutte PM
J Pharmacol Exp Ther; 1985 Oct; 235(1):81-6. PubMed ID: 3930700
[TBL] [Abstract][Full Text] [Related]
19. Endothelium-derived relaxing factor is likely to modulate the tone of resistance arteries in rabbit hindlimb in vivo.
Förstermann U; Dudel C; Frölich JC
J Pharmacol Exp Ther; 1987 Dec; 243(3):1055-61. PubMed ID: 2447263
[TBL] [Abstract][Full Text] [Related]
20. Cultured dog aortic endothelial cells release vasodilatory products in response to acetylcholine and adenosine.
Woodley N; Barclay JK
Can J Physiol Pharmacol; 1996 Aug; 74(8):949-56. PubMed ID: 8960385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
